{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:36:39Z","timestamp":1785818199913,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer's disease (AD) is a heritable neurodegenerative disease whose long asymptomatic phase makes the early diagnosis of it pivotal. Blood U-p53 has recently emerged as a superior predictive biomarker for AD in the early stages. We hypothesized that genetic variants associated with blood U-p53 could reveal novel loci and pathways involved in the early stages of AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We performed a blood U-p53 Genome-wide association study (GWAS) on 484 healthy and mild cognitively impaired subjects from the ADNI cohort using 612,843 Single nucleotide polymorphisms (SNPs). We performed a pathway analysis and prioritized candidate genes using an AD single-cell gene program. We fine-mapped the intergenic SNPs by leveraging a cell-type-specific enhancer-to-gene linking strategy using a brain single-cell multimodal dataset. We validated the candidate genes in an independent brain single-cell RNA-seq and the ADNI blood transcriptome datasets. The rs279686 between AASS and FEZF1 genes was the most significant SNP (\n                      <jats:italic>p<\/jats:italic>\n                      -value\u2009=\u20094.82\u2009\u00d7\u200910\n                      <jats:sup>\u20137<\/jats:sup>\n                      ). Suggestive pathways were related to the immune and nervous systems. Twenty-three candidate genes were prioritized at 27 suggestive loci. Fine-mapping of 5 intergenic loci yielded nine cell-specific candidate genes. Finally, 15 genes were validated in the independent single-cell RNA-seq dataset, and five were validated in the ADNI blood transcriptome dataset.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We underlined the importance of performing a GWAS on an early-stage biomarker of AD and leveraging functional omics datasets for pinpointing causal genes in AD. Our study prioritized nine genes (SORCS1, KIF5C, TMEFF2, TMEM63C, HLA-E, ATAT1, TUBB, ARID1B, and RUNX1) strongly implicated in the early stages of AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12864-024-10363-6","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T06:02:24Z","timestamp":1714716144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Unraveling the genetic architecture of blood unfolded p-53 among non-demented elderlies: novel candidate genes for early Alzheimer's disease"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-8590","authenticated-orcid":false,"given":"Arash","family":"Yaghoobi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3525-3548","authenticated-orcid":false,"given":"Seyed Amir","family":"Malekpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"issue":"4","key":"10363_CR1","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3233\/JAD-180416","volume":"66","author":"I Bacigalupo","year":"2018","unstructured":"Bacigalupo I, Mayer F, Lacorte E, Di Pucchio A, Marzolini F, Canevelli M, et al. A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria. J Alzheimers Dis. 2018;66(4):1471\u201381.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10363_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","volume":"15","author":"B Winblad","year":"2016","unstructured":"Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, et al. Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455\u2013532.","journal-title":"Lancet Neurol"},{"issue":"1","key":"10363_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","volume":"9","author":"PS Aisen","year":"2017","unstructured":"Aisen PS, Cummings J, Jack CR Jr, Morris JC, Sperling R, Fr\u00f6lich L, et al. On the path to 2025: understanding the Alzheimer\u2019s disease continuum. Alzheimers Res Ther. 2017;9(1):60.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10363_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10363_CR5","first-page":"313","volume":"8","author":"XX Zhang","year":"2021","unstructured":"Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu JT. The Epidemiology of Alzheimer\u2019s Disease Modifiable Risk Factors and Prevention. J Prev Alzheimers Dis. 2021;8(3):313\u201321.","journal-title":"J Prev Alzheimers Dis"},{"key":"10363_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnins.2018.00025","volume":"12","author":"F Kametani","year":"2018","unstructured":"Kametani F, Hasegawa M. Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer\u2019s Disease. Front Neurosci. 2018;12:25.","journal-title":"Front Neurosci"},{"issue":"40","key":"10363_CR7","doi-asserted-by":"publisher","first-page":"9096","DOI":"10.1523\/JNEUROSCI.1697-05.2005","volume":"25","author":"M Buttini","year":"2005","unstructured":"Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, Johnson-Wood K, et al. Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2005;25(40):9096\u2013101.","journal-title":"J Neurosci"},{"issue":"4","key":"10363_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2014;370(4):311\u201321.","journal-title":"N Engl J Med"},{"issue":"4","key":"10363_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2014;370(4):322\u201333.","journal-title":"N Engl J Med"},{"key":"10363_CR10","doi-asserted-by":"publisher","first-page":"835288","DOI":"10.3389\/fnagi.2022.835288","volume":"14","author":"JS Clark","year":"2022","unstructured":"Clark JS, Kayed R, Abate G, Uberti D, Kinnon P, Piccirella S. Post-translational Modifications of the p53 Protein and the Impact in Alzheimer\u2019s Disease: A Review of the Literature. Front Aging Neurosci. 2022;14:835288.","journal-title":"Front Aging Neurosci"},{"issue":"50","key":"10363_CR11","doi-asserted-by":"publisher","first-page":"18055","DOI":"10.1073\/pnas.1419083111","volume":"111","author":"P Merlo","year":"2014","unstructured":"Merlo P, Frost B, Peng S, Yang YJ, Park PJ, Feany M. p53 prevents neurodegeneration by regulating synaptic genes. Proc Natl Acad Sci U S A. 2014;111(50):18055\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10363_CR12","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/sj.emboj.7601292","volume":"25","author":"S Di Giovanni","year":"2006","unstructured":"Di Giovanni S, Knights CD, Rao M, Yakovlev A, Beers J, Catania J, et al. The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. Embo j. 2006;25(17):4084\u201396.","journal-title":"Embo j"},{"issue":"6","key":"10363_CR13","doi-asserted-by":"publisher","first-page":"e99897","DOI":"10.1371\/journal.pone.0099897","volume":"9","author":"AR Silva","year":"2014","unstructured":"Silva AR, Santos AC, Farfel JM, Grinberg LT, Ferretti RE, Campos AH, et al. Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer\u2019s disease. PLoS ONE. 2014;9(6):e99897.","journal-title":"PLoS ONE"},{"issue":"3","key":"10363_CR14","first-page":"469","volume":"9","author":"S Piccirella","year":"2022","unstructured":"Piccirella S, Van Neste L, Fowler C, Masters CL, Fripp J, Doecke JD, et al. A Conformational Variant of p53 (U-p53AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer\u2019s Disease. J Prev Alzheimers Dis. 2022;9(3):469\u201379.","journal-title":"J Prev Alzheimers Dis"},{"issue":"Pt 15","key":"10363_CR15","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1242\/jcs.115.15.3131","volume":"115","author":"D Uberti","year":"2002","unstructured":"Uberti D, Carsana T, Bernardi E, Rodella L, Grigolato P, Lanni C, et al. Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer\u2019s disease patients. J Cell Sci. 2002;115(Pt 15):3131\u20138.","journal-title":"J Cell Sci"},{"issue":"12","key":"10363_CR16","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.4103\/1673-5374.339476","volume":"17","author":"PW French","year":"2022","unstructured":"French PW. Unfolded p53 in non-neuronal cells supports bacterial etiology of Alzheimer\u2019s disease. Neural Regen Res. 2022;17(12):2619\u201322.","journal-title":"Neural Regen Res"},{"issue":"1","key":"10363_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13195-020-00732-0","volume":"12","author":"G Abate","year":"2020","unstructured":"Abate G, Frisoni GB, Bourdon JC, Piccirella S, Memo M, Uberti D. The pleiotropic role of p53 in functional\/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12(1):160.","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"10363_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tins.2004.06.005","volume":"27","author":"RG Shulman","year":"2004","unstructured":"Shulman RG, Rothman DL, Behar KL, Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci. 2004;27(8):489\u201395.","journal-title":"Trends Neurosci"},{"issue":"3","key":"10363_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pneurobio.2005.02.004","volume":"75","author":"ZZ Chong","year":"2005","unstructured":"Chong ZZ, Li F, Maiese K. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol. 2005;75(3):207\u201346.","journal-title":"Prog Neurobiol"},{"issue":"15","key":"10363_CR20","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1074\/jbc.M607483200","volume":"282","author":"FG De Felice","year":"2007","unstructured":"De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, et al. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem. 2007;282(15):11590\u2013601.","journal-title":"J Biol Chem"},{"issue":"4","key":"10363_CR21","doi-asserted-by":"publisher","first-page":"e10171","DOI":"10.1371\/journal.pone.0010171","volume":"5","author":"C Lanni","year":"2010","unstructured":"Lanni C, Nardinocchi L, Puca R, Stanga S, Uberti D, Memo M, et al. Homeodomain interacting protein kinase 2: a target for Alzheimer\u2019s beta amyloid leading to misfolded p53 and inappropriate cell survival. PLoS ONE. 2010;5(4):e10171.","journal-title":"PLoS ONE"},{"issue":"5","key":"10363_CR22","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/jnc.12154","volume":"125","author":"C Lanni","year":"2013","unstructured":"Lanni C, Necchi D, Pinto A, Buoso E, Buizza L, Memo M, et al. Zyxin is a novel target for \u03b2-amyloid peptide: characterization of its role in Alzheimer\u2019s pathogenesis. J Neurochem. 2013;125(5):790\u20139.","journal-title":"J Neurochem"},{"issue":"1","key":"10363_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1471-4159.2007.04757.x","volume":"103","author":"D Uberti","year":"2007","unstructured":"Uberti D, Cenini G, Olivari L, Ferrari-Toninelli G, Porrello E, Cecchi C, et al. Over-expression of amyloid precursor protein in HEK cells alters p53 conformational state and protects against doxorubicin. J Neurochem. 2007;103(1):322\u201333.","journal-title":"J Neurochem"},{"issue":"4","key":"10363_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/acel.12335","volume":"14","author":"AK Singh","year":"2015","unstructured":"Singh AK, Pati U. CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of \u03b2-secretase. Aging Cell. 2015;14(4):595\u2013604.","journal-title":"Aging Cell"},{"key":"10363_CR25","doi-asserted-by":"publisher","first-page":"352723","DOI":"10.1155\/2015\/352723","volume":"2015","author":"Z Liu","year":"2015","unstructured":"Liu Z, Li T, Li P, Wei N, Zhao Z, Liang H, et al. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer\u2019s Disease. Oxid Med Cell Longev. 2015;2015:352723.","journal-title":"Oxid Med Cell Longev"},{"key":"10363_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2013.10.026","volume":"256","author":"S Zahid","year":"2014","unstructured":"Zahid S, Khan R, Oellerich M, Ahmed N, Asif AR. Differential S-nitrosylation of proteins in Alzheimer\u2019s disease. Neuroscience. 2014;256:126\u201336.","journal-title":"Neuroscience"},{"issue":"8","key":"10363_CR27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","volume":"16","author":"GB Frisoni","year":"2017","unstructured":"Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, et al. Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers. Lancet Neurol. 2017;16(8):661\u201376.","journal-title":"Lancet Neurol"},{"key":"10363_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-030-05542-4_2","volume":"1118","author":"J Cummings","year":"2019","unstructured":"Cummings J. The Role of Biomarkers in Alzheimer\u2019s Disease Drug Development. Adv Exp Med Biol. 2019;1118:29\u201361.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10363_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10363_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/jpm11010014","volume":"11","author":"G Abate","year":"2020","unstructured":"Abate G, Vezzoli M, Polito L, Guaita A, Albani D, Marizzoni M, et al. A conformation variant of p53 combined with machine learning identifies Alzheimer disease in preclinical and prodromal stages. J Pers Med. 2020;11(1):14. https:\/\/doi.org\/10.3390\/jpm11010014.","journal-title":"J Pers Med"},{"issue":"2","key":"10363_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168\u201374.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"10363_CR32","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1038\/s41380-023-02089-w","volume":"28","author":"J Lake","year":"2023","unstructured":"Lake J, Warly Solsberg C, Kim JJ, Acosta-Uribe J, Makarious MB, Li Z, et al. Multi-ancestry meta-analysis and fine-mapping in Alzheimer\u2019s disease. Mol Psychiatry. 2023;28(7):3121\u201332. https:\/\/doi.org\/10.1038\/s41380-023-02089-w.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10363_CR33","doi-asserted-by":"publisher","first-page":"fcac125","DOI":"10.1093\/braincomms\/fcac125","volume":"4","author":"V Escott-Price","year":"2022","unstructured":"Escott-Price V, Hardy J. Genome-wide association studies for Alzheimer\u2019s disease: bigger is not always better. Brain Commun. 2022;4(3):fcac125.","journal-title":"Brain Commun."},{"issue":"5","key":"10363_CR34","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-022-02454-z","volume":"144","author":"IE Jansen","year":"2022","unstructured":"Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, et al. Genome-wide meta-analysis for Alzheimer\u2019s disease cerebrospinal fluid biomarkers. Acta Neuropathol. 2022;144(5):821\u201342.","journal-title":"Acta Neuropathol"},{"key":"10363_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fnagi.2019.00297","volume":"11","author":"C Liu","year":"2019","unstructured":"Liu C, Yu J. Genome-Wide Association Studies for Cerebrospinal Fluid Soluble TREM2 in Alzheimer\u2019s Disease. Front Aging Neurosci. 2019;11:297.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10363_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-022-00592-2","volume":"18","author":"SR Oatman","year":"2023","unstructured":"Oatman SR, Reddy JS, Quicksall Z, Carrasquillo MM, Wang X, Liu CC, et al. Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer\u2019s disease related proteins. Mol Neurodegener. 2023;18(1):2.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10363_CR37","doi-asserted-by":"publisher","first-page":"e1004714","DOI":"10.1371\/journal.pcbi.1004714","volume":"12","author":"D Lamparter","year":"2016","unstructured":"Lamparter D, Marbach D, Rueedi R, Kutalik Z, Bergmann S. Fast and Rigorous Computation of Gene and Pathway Scores from SNP-Based Summary Statistics. PLoS Comput Biol. 2016;12(1):e1004714.","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"10363_CR38","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/s41588-022-01187-9","volume":"54","author":"KA Jagadeesh","year":"2022","unstructured":"Jagadeesh KA, Dey KK, Montoro DT, Mohan R, Gazal S, Engreitz JM, et al. Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics. Nat Genet. 2022;54(10):1479\u201392.","journal-title":"Nat Genet"},{"issue":"3","key":"10363_CR39","doi-asserted-by":"publisher","first-page":"100263","DOI":"10.1016\/j.xgen.2023.100263","volume":"3","author":"AG Anderson","year":"2023","unstructured":"Anderson AG, Rogers BB, Loupe JM, Rodriguez-Nunez I, Roberts SC, White LM, et al. Single nucleus multiomics identifies ZEB1 and MAFB as candidate regulators of Alzheimer\u2019s disease-specific cis-regulatory elements. Cell Genom. 2023;3(3):100263.","journal-title":"Cell Genom"},{"key":"10363_CR40","doi-asserted-by":"crossref","unstructured":"Sakaue S, Weinand K, Dey KK, Jagadeesh K, Kanai M, Watts GFM, et al. Tissue-specific enhancer-gene maps from multimodal single-cell data identify causal disease alleles. medRxiv. 2022:2022.10.27.22281574.","DOI":"10.1101\/2022.10.27.22281574"},{"issue":"8","key":"10363_CR41","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41588-021-00894-z","volume":"53","author":"S Morabito","year":"2021","unstructured":"Morabito S, Miyoshi E, Michael N, Shahin S, Martini AC, Head E, et al. Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer\u2019s disease. Nat Genet. 2021;53(8):1143\u201355.","journal-title":"Nat Genet"},{"issue":"1","key":"10363_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","volume":"88","author":"J Yang","year":"2011","unstructured":"Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88(1):76\u201382.","journal-title":"Am J Hum Genet"},{"key":"10363_CR43","doi-asserted-by":"crossref","unstructured":"Wen J, Zhao B, Yang Z, Erus G, Skampardoni I, Mamourian E, et al. The Genetic Architecture of Multimodal Human Brain Age. bioRxiv. 2023:2023.04.13.536818.","DOI":"10.1101\/2023.04.13.536818"},{"issue":"16","key":"10363_CR44","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.3390\/ijms23168972","volume":"23","author":"E Sun","year":"2022","unstructured":"Sun E, Motolani A, Campos L, Lu T. The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer\u2019s disease. Int J Mol Sci. 2022;23(16):8972. https:\/\/doi.org\/10.3390\/ijms23168972.","journal-title":"Int J Mol Sci"},{"key":"10363_CR45","doi-asserted-by":"publisher","first-page":"104511","DOI":"10.1016\/j.ebiom.2023.104511","volume":"90","author":"SJ Andrews","year":"2023","unstructured":"Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM. The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. EBioMedicine. 2023;90:104511.","journal-title":"EBioMedicine"},{"issue":"5","key":"10363_CR46","doi-asserted-by":"publisher","first-page":"e63621","DOI":"10.1371\/journal.pone.0063621","volume":"8","author":"W Xu","year":"2013","unstructured":"Xu W, Xu J, Wang Y, Tang H, Deng Y, Ren R, et al. The genetic variation of SORCS1 is associated with late-onset Alzheimer\u2019s disease in Chinese Han population. PLoS ONE. 2013;8(5):e63621.","journal-title":"PLoS ONE"},{"issue":"1","key":"10363_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ana.22308","volume":"69","author":"C Reitz","year":"2011","unstructured":"Reitz C, Tokuhiro S, Clark LN, Conrad C, Vonsattel JP, Hazrati LN, et al. SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer\u2019s disease risk. Ann Neurol. 2011;69(1):47\u201364.","journal-title":"Ann Neurol"},{"issue":"39","key":"10363_CR48","doi-asserted-by":"publisher","first-page":"13110","DOI":"10.1523\/JNEUROSCI.3872-10.2010","volume":"30","author":"RF Lane","year":"2010","unstructured":"Lane RF, Raines SM, Steele JW, Ehrlich ME, Lah JA, Small SA, et al. Diabetes-associated SorCS1 regulates Alzheimer\u2019s amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex. J Neurosci. 2010;30(39):13110\u20135.","journal-title":"J Neurosci"},{"key":"10363_CR49","doi-asserted-by":"publisher","unstructured":"Lee AK, Yi N, Khaled H, Feller B, Takahashi H. SorCS1 inhibits amyloid-\u03b2 binding to neurexin and rescues amyloid-\u03b2-induced synaptic pathology. Life Sci Alliance. 2023;6(4):e202201681. https:\/\/doi.org\/10.26508\/lsa.202201681.","DOI":"10.26508\/lsa.202201681"},{"issue":"3","key":"10363_CR50","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3233\/JAD-150318","volume":"48","author":"HS Hong","year":"2015","unstructured":"Hong HS, Maezawa I, Petrlova J, Zhao XY, John CV, Jin LW. Tomoregulin (TMEFF2) binds alzheimer\u2019s disease amyloid-\u03b2 (A\u03b2) oligomer and A\u03b2PP and protects neurons from A\u03b2-induced toxicity. J Alzheimers Dis. 2015;48(3):731\u201343.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10363_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","volume":"76","author":"S Kim","year":"2011","unstructured":"Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, et al. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology. 2011;76(1):69\u201379.","journal-title":"Neurology"},{"issue":"3","key":"10363_CR52","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s12035-014-8810-x","volume":"51","author":"ZX Wang","year":"2015","unstructured":"Wang ZX, Tan L, Yu JT. Axonal transport defects in Alzheimer\u2019s disease. Mol Neurobiol. 2015;51(3):1309\u201321.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10363_CR53","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/mp.2013.19","volume":"19","author":"VK Ramanan","year":"2014","unstructured":"Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, et al. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Mol Psychiatry. 2014;19(3):351\u20137.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10363_CR54","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41380-021-01060-x","volume":"27","author":"JJ Moffat","year":"2022","unstructured":"Moffat JJ, Smith AL, Jung EM, Ka M, Kim WY. Neurobiology of ARID1B haploinsufficiency related to neurodevelopmental and psychiatric disorders. Mol Psychiatry. 2022;27(1):476\u201389.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10363_CR55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neulet.2010.10.010","volume":"487","author":"A Patel","year":"2011","unstructured":"Patel A, Rees SD, Kelly MA, Bain SC, Barnett AH, Thalitaya D, et al. Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer\u2019s disease in subjects with Down syndrome. Neurosci Lett. 2011;487(2):144\u20138.","journal-title":"Neurosci Lett"},{"issue":"6","key":"10363_CR56","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1182\/bloodadvances.2019000785","volume":"4","author":"DC Bellissimo","year":"2020","unstructured":"Bellissimo DC, Chen CH, Zhu Q, Bagga S, Lee CT, He B, et al. Runx1 negatively regulates inflammatory cytokine production by neutrophils in response to Toll-like receptor signaling. Blood Adv. 2020;4(6):1145\u201358.","journal-title":"Blood Adv"},{"issue":"10","key":"10363_CR57","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.18632\/aging.203883","volume":"14","author":"W Zhang","year":"2022","unstructured":"Zhang W, Yang Y, Xiang Z, Cheng J, Yu Z, Wang W, et al. MRTF-A-mediated protection against amyloid-\u03b2-induced neuronal injury correlates with restoring autophagy via miR-1273g-3p\/mTOR axis in Alzheimer models. Aging (Albany NY). 2022;14(10):4305\u201325.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10363_CR58","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/WAD.0000000000000185","volume":"31","author":"MJ Lazarczyk","year":"2017","unstructured":"Lazarczyk MJ, Haller S, Savioz A, Gimelli S, Bena F, Giannakopoulos P. Heterozygous Deletion of Chorein Exons 70\u201373 and GNA14 Exons 3\u20137 in a Brazilian Patient Presenting With Probable Tau-Negative Early-Onset Alzheimer Disease. Alzheimer Dis Assoc Disord. 2017;31(1):82\u20135.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"10","key":"10363_CR59","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1038\/s41380-020-01003-y","volume":"26","author":"J Park","year":"2021","unstructured":"Park J, Choi H, Kim YD, Kim SH, Kim Y, Gwon Y, et al. Aberrant role of ALK in tau proteinopathy through autophagosomal dysregulation. Mol Psychiatry. 2021;26(10):5542\u201356.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10363_CR60","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1038\/s41467-023-40208-x","volume":"14","author":"M Askenazi","year":"2023","unstructured":"Askenazi M, Kavanagh T, Pires G, Ueberheide B, Wisniewski T, Drummond E. Compilation of reported protein changes in the brain in Alzheimer\u2019s disease. Nat Commun. 2023;14(1):4466.","journal-title":"Nat Commun"},{"issue":"2","key":"10363_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson ECB, Carter EK, Dammer EB, Duong DM, Gerasimov ES, Liu Y, et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci. 2022;25(2):213\u201325.","journal-title":"Nat Neurosci"},{"key":"10363_CR62","doi-asserted-by":"publisher","first-page":"105247","DOI":"10.1016\/j.nbd.2020.105247","volume":"151","author":"FHG Farias","year":"2021","unstructured":"Farias FHG, Benitez BA, Cruchaga C. Quantitative endophenotypes as an alternative approach to understanding genetic risk in neurodegenerative diseases. Neurobiol Dis. 2021;151:105247.","journal-title":"Neurobiol Dis"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-024-10363-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-024-10363-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-024-10363-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T07:02:00Z","timestamp":1714719720000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-024-10363-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10363"],"URL":"https:\/\/doi.org\/10.1186\/s12864-024-10363-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3357613\/v1","asserted-by":"object"}]},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"440"}}